XML 25 R12.htm IDEA: XBRL DOCUMENT v3.25.4
Note 5 - Earnings Per Common Share
6 Months Ended
Dec. 31, 2025
Notes to Financial Statements  
Earnings Per Share [Text Block]

NOTE 5 - EARNINGS PER COMMON SHARE

 

The following table presents the amounts used to compute basic and diluted earnings per common share, as well as the effect of dilutive potential common shares on weighted average shares outstanding:

 

  

Three Months Ended

  

Six Months Ended

 
  

December 31

  

December 31

 
  

2025

  

2024

  

2025

  

2024

 
                 

BASIC EARNINGS PER SHARE

                
                 

Net income

 $6,348  $5,647  $13,612  $12,329 
                 

Weighted average shares outstanding during the period, net of treasury shares

  30,019   28,848   29,682   28,681 

Weighted average vested restricted stock units outstanding

  61   72   52   81 

Weighted average shares outstanding in the Deferred Compensation Plan during the period

  1,077   1,010   1,069   999 

Weighted average shares outstanding

  31,157   29,930   30,803   29,761 
                 

Basic earnings per common share

 $0.20  $0.19  $0.44  $0.41 
                 
                 

DILUTED EARNINGS PER SHARE

                
                 

Net income

 $6,348  $5,647  $13,612  $12,329 
                 

Weighted average shares outstanding:

                
                 

Basic

  31,157   29,930   30,803   29,761 
                 

Effect of dilutive securities (a):

                

Impact of common shares to be issued under stock option plans, and contingently issuable shares, if any

  847   946   882   948 

Weighted average shares outstanding

  32,004   30,876   31,685   30,709 
                 

Diluted earnings per common share

 $0.20  $0.18  $0.43  $0.40 
                 

Anti-dilutive securities (b)

  4   265   2   265 

 

 

(a)

Calculated using the “Treasury Stock” method as if dilutive securities were exercised and the funds were used to purchase common shares at the average market price during the period.

 

 

(b)

Anti-dilutive securities were excluded from the computation of diluted net income per share for the three and six months ended December 31, 2025, and December 31, 2024, because the exercise price was greater than the average fair market price of the common shares or because the assumed proceeds from the award’s exercise or vesting was greater than the average fair market price of the common shares.